Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 16;11(7):438-442.
doi: 10.4253/wjge.v11.i7.438.

Endoscopic management of massive rectal bleeding from a Dieulafoy's lesion: Case report

Affiliations
Review

Endoscopic management of massive rectal bleeding from a Dieulafoy's lesion: Case report

Mario Rene Pineda-De Paz et al. World J Gastrointest Endosc. .

Abstract

Background: Rectal Dieulafoy's lesions (DLs) are very rare; however, they can be life threatening when presented with massive hemorrhage.

Case summary: A 44-year-old female with medical history of chronic renal failure who was on renal replacement therapy presented with lower gastrointestinal hemorrhage. Physical examination revealed signs of hypovolemic shock and massive rectal bleeding. Complete blood count revealed abrupt decrease in hematocrit. After hemodynamic stabilization, an urgent colonoscopy was performed. A rectal DL was diagnosed, and it was successfully treated with two hemoclips. There were no signs of recurrent bleeding at thirty days of follow-up.

Conclusion: Rectal DLs represent an unusual cause of lower gastrointestinal bleeding. Massive hemorrhage can increase the morbidity and mortality of these patients. Endoscopic management continues to be the reference standard in the diagnosis and therapy of these lesions. Thermal, mechanical (hemoclip or band ligation), or combination therapy (adrenaline injection combined with thermal or mechanical therapy) should be considered the first choice for treatment.

Keywords: Case report; Dieulafoy's Lesion; Endoscopic hemostasis; Massive rectal bleeding.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: Authors declare no conflict of interest regarding this manuscript.

Figures

Figure 1
Figure 1
Endoscopic appearance of Dieulfoy's lesion. A small pigmented protuberance with minimal surrounding erosion and no ulcerative lesion.
Figure 2
Figure 2
Endoscopic management of Dieulafoy’s lesion. A: Placement of the first hemoclip; B: Placement of a second hemoclip to ensure hemostasis.

Similar articles

Cited by

References

    1. Chaer RA, Helton WS. Dieulafoy's disease. J Am Coll Surg. 2003;196:290–296. - PubMed
    1. Lara LF, Sreenarasimhaiah J, Jiang Tang S, Alonso BB, Rochey DC. Localization, efficacy of therapy and outcomes of Dieulafoy's lesions of the GI tract-the UT Southwestern GI Bleed Team experience. Gastrointest Endosc. 2008;67:AB87.
    1. Lee YT, Walmsley RS, Leong RW, Sung JJ. Dieulafoy's lesion. Gastrointest Endosc. 2003;58:236–243. - PubMed
    1. Tursi A. Rectal Dieulafoy lesion. Clin Res Hepatol Gastroenterol. 2017;41:1–2. - PubMed
    1. Kanth R, Mali P, Roy PK. Outcomes in Dieulafoy's Lesion: A 10-Year Clinical Review. Dig Dis Sci. 2015;60:2097–2103. - PubMed